Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prostate Cancer Recurrent × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Genitourinary 1

Conditions

Polycystic Ovary Syndrome 122 Prostatic Neoplasms 28 Breast Neoplasms 28 Insulin Resistance 26 Obesity 14 Pancreatic Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Endometrial Neoplasms 11 Neoplasms 10 Infertility 10 Colorectal Neoplasms 10 Anovulation 9 Lung Neoplasms 8 Metabolic Syndrome 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Melanoma 6 Hyperandrogenism 6 Diabetes Mellitus 6 Adenocarcinoma 5 Weight Loss 4 Rectal Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Urinary Bladder Neoplasms 3 Recurrence 3 Ovarian Neoplasms 3

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 testosterone undecanoate 1 Sirolimus 1 Nelfinavir 1 Metformin 1 Hydroxychloroquine 1 Gonadotropins 1 Diet, Protein-Restricted 1 Dasatinib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036226 2025-10-06

COAST

Medical University of South Carolina

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡